Presentation Information
[SY-27-01]Case Conference: Approaches to Treatment-Resistant Schizophrenia in Patients Who Have Committed Serious Criminal Acts
*Kenichi Kimura1,2,3, Chommakorn Thanetnit4, Emily Ohki5,3, Wonseok Lee6 (1.Forensic Psychiatry Center, Hokkaido University Hospital(Japan), 2.Hokkaido Prefectural Koyogaoka Hospital(Japan), 3.Japan Young Psychiatrists Organization(Japan), 4.Department of Psychiatry, Thammasat University Hospital(Thailand), 5.Tokyo Metropolitan Matsuzawa Hospital(Japan), 6.Department of Psychiatry, Jeju National University Hospital(Korea))
Keywords:
Forensic psychiatry,Treatment-resistant schizophrenia,Criminal behavior,Court-ordered psychiatric treatment,Law and psychiatry
This case conference aims to explore comprehensive strategies for managing treatment-resistant schizophrenia in patients with a history of serious criminal behavior. Using a case vignette, we will discuss and compare the biological and psychosocial approaches to treatment across different countries, as well as the legal and institutional frameworks that support the management of such patients.
Discussions will focus on the following key questions:
① What is your diagnosis and treatment plan for this patient?
② What biological treatments, including pharmacotherapy and neuromodulation, are available in your country for treatment-resistant schizophrenia?
③ What psychosocial interventions, including psychotherapy approaches and community-based living facilities, are available in your country for treatment-resistant schizophrenia?
④ Does your country have specialized hospitalization or facilities for treating schizophrenia or other mental disorders in patients with serious criminal behavior?
This session seeks to promote a deeper understanding of the challenges and opportunities in treating this unique patient population. By comparing practices and frameworks globally, we hope to facilitate the exchange of knowledge, innovative strategies, and best practices among professionals.
Discussions will focus on the following key questions:
① What is your diagnosis and treatment plan for this patient?
② What biological treatments, including pharmacotherapy and neuromodulation, are available in your country for treatment-resistant schizophrenia?
③ What psychosocial interventions, including psychotherapy approaches and community-based living facilities, are available in your country for treatment-resistant schizophrenia?
④ Does your country have specialized hospitalization or facilities for treating schizophrenia or other mental disorders in patients with serious criminal behavior?
This session seeks to promote a deeper understanding of the challenges and opportunities in treating this unique patient population. By comparing practices and frameworks globally, we hope to facilitate the exchange of knowledge, innovative strategies, and best practices among professionals.